TGA grant provisional approval for Pfizer vaccine for 12-15 years

On 22 July 2021, the TGA grants provisional approval for Pfizer COVID-19 vaccine for use in 12 to 15 year olds.

“The Therapeutic Goods Administration (TGA) has thoroughly, and independently, assessed the domestic and international evidence before extending its approval for the Pfizer vaccine to be administered to this age group.” [1, 2]

ATAGI was states as having “been meeting with global experts over recent days to inform their deliberations and expert advice,” indicating that much or all of the data is coming from international regulator experience.

At this time just under 15% of Australians had received 2 doses.